Am. Gerdes et al., EFFECT OF INCREASED GENE DOSAGE EXPRESSION ON THE ALPHA-INTERFERON RECEPTORS IN DOWNS-SYNDROME, Biochimica et biophysica acta, 1181(2), 1993, pp. 135-140
The gene coding for the alpha,beta-interferon (alpha,beta-IFN) recepto
r is localized to chromosome 21. Cells from patients with Down's syndr
ome contain an extra chromosome 21, and thereby an expected 1.5-times
increase in the number of genes located to this chromosome and in cons
equence a 1.5-times increase in cell surface alpha-IFN receptors. Actu
al measurements of these by competition binding experiments with human
recombinant alpha-IFN on peripheral blood mononuclear cells (PBMC) fr
om patients with Down's syndrome resulted in a mean of 1.69, which is
in accordance to the theoretical 1.50, but slightly overestimated due
to the calculation method. The increased gene dosage of the alpha-IFN
receptor was quantitatively verified by Southern blot-hybridizations.
Further characterization of alpha-IFN receptor binding showed insignif
icant differences in dissociation constants among patients and healthy
individuals.